CH Biotech R&D Co., Ltd.

TWSE:6534 Stock Report

Market Cap: NT$9.3b

CH Biotech R&D Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Wen Ren Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.003%
Management average tenure8.8yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

Analysis Article • Mar 10

Solid Earnings May Not Tell The Whole Story For CH Biotech R&D (TWSE:6534)

The recent earnings posted by CH Biotech R&D Co., Ltd. ( TWSE:6534 ) were solid, but the stock didn't move as much as...
Analysis Article • Apr 05

CH Biotech R&D (GTSM:6534) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • Mar 18

A Look At CH Biotech R&D's (GTSM:6534) Share Price Returns

We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly...
Analysis Article • Feb 09

Are CH Biotech R&D Co., Ltd.'s (GTSM:6534) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

It is hard to get excited after looking at CH Biotech R&D's (GTSM:6534) recent performance, when its stock has declined...
Analysis Article • Jan 11

Returns On Capital At CH Biotech R&D (GTSM:6534) Paint An Interesting Picture

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Analysis Article • Dec 15

Does CH Biotech R&D (GTSM:6534) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Nov 24

Tread With Caution Around CH Biotech R&D Co., Ltd.'s (GTSM:6534) 1.8% Dividend Yield

Dividend paying stocks like CH Biotech R&D Co., Ltd. (GTSM:6534) tend to be popular with investors, and for good...

CEO

Wen Ren Chen

no data
Tenure

Wen Ren Chen is Manager of CH Biotech R&D Co. Ltd.

Leadership Team

NamePositionTenureCompensationOwnership
Wen Ren Chen
Managerno datano data0.0029%
NT$ 270.5k
Hsiu-Feng Lin
Assistant Vice President of Finance Department8.8yrsno datano data
Xinjun Luo
Accounting Supervisorno datano datano data
Mu-Sheng Lin
Chief of Board Office8.8yrsno data0.056%
NT$ 5.2m
Kuei-Chun Li
Head of R&D Department6.6yrsno datano data
8.8yrs
Average Tenure

Experienced Management: 6534's management team is seasoned and experienced (8.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Cheng-Pang Wu
Chairman12.7yrsno data22.08%
NT$ 2.0b
Chao-Tsung Chiu
Director8.1yrsno data0.15%
NT$ 14.0m
Yung Ming Chou
Director5.8yrsno datano data
Yong-Xiang Chiu
Independent Director4.8yrsno datano data
Robert James Christopher Clayton
Institutional Director3.2yrsno datano data
Wan-Yu Liu
Independent Director2.5yrsno datano data
Yin-Hsiang Chou
Independent Director2.5yrsno datano data
Jesse Wu
Director2.5yrsno data0.16%
NT$ 14.5m
Ching-Chuan Chang
Director1.5yrsno data2.48%
NT$ 229.3m
3.2yrs
Average Tenure

Experienced Board: 6534's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 12:30
End of Day Share Price 2026/07/06 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CH Biotech R&D Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yenya KuoCapital Securities Corporation
Hsiu Chi LinMasterlink Securities Investment Advisory